Ringkjobing Landbobank A/sOMXCOP: RILBA

Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025

· Issued by Ringkjobing Landbobank A/S

Nasdaq Copenhagen
Euronext Dublin
London Stock Exchange
Other stakeholders

22 October 2025

Ringkjøbing Landbobank’s quarterly report for the three quarters of 2025

The bank’s board of directors and general management today approved the report for the first three quarters of 2025.

The bank delivers core earnings of DKK 2,321 million and net profit of DKK 1,753 million in the first three quarters of the year. The net profit is equivalent to a 21% p.a. return on equity.

Core earnings

(DKK million)

Q1-Q3 2025

Q1-Q3 2024

2024

2023

2022

2021

Total core income

2,090

3,067

4,068

3,828

2,862

2,433

Total expenses and depreciation

534

761

1,044

963

891

817

Core earnings before impairment charges for loans

1,556

2,306

3,024

2,865

1,971

1,616

Impairment charges for loans etc.

+24

+2

+3

-1

-2

-68

Core earnings

1,580

2,308

3,027

2,864

1,969

1,548

Result for the portfolio etc.

-4

+56

+62

-7

-69

+7

Amortisation and write-downs on intangible assets

10

15

20

20

20

17

Tax

375

579

768

682

385

309

Net profit

1,191

1,770

2,301

2,155

1,495

1,229

Highlights of the first half of 2025

  • The net profit is DKK 1,753 million, equivalent to a 21% p.a. return on equity

  • Earnings per share (net profit) increase by 4% to DKK 71.2 for the first three quarters of 2025

  • Core income is DKK 3,073 million, marginally higher than in the same period in 2024

  • Costs increase by 4%, and the cost/income ratio is 25.6%

  • Continued strong credit quality means that impairment charges of DKK 11 million were carried to income in the quarter and that impairment charges in the first three quarters of 2025 represented income totalling DKK 35 million

  • Highly satisfactory increase in customer numbers and growth of 7% p.a. in loans and 9% p.a. in deposits

Yours sincerely

Ringkjøbing Landbobank

John Fisker
CEO

Attachments